-
MDA Ambassador Guest Blog: Building Confidence in the Classroom
Madison Helaire is an 18-year-old, upcoming nursing major from Baton Rouge, Louisiana. Madison has congenital muscular dystrophy and enjoys reading and baking for fun. As a teenage girl living with a disability like congenital muscular dystrophy (CMD), life can be rather hard. I will be a freshman in college this August, and throughout my years…
-
Biotech raises $90M for late-stage testing of FSHD treatment
Epicrispr Biotechnologies has raised $90 million in financing to support late-stage clinical testing of EPI-321, the company’s epigenetic treatment candidate for facioscapulohumeral muscular dystrophy (FSHD). “This financing marks a pivotal milestone for Epicrispr as we advance EPI-321 and the next generation of programmable epigenetic medicines,” Amber Salzman, PhD, CEO of Epicrispr, said in a company…








